These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21042946)

  • 1. Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer.
    Eom BW; Ryu KW; Lee JH; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Park SR; Lee JS; Kim YW
    Ann Surg Oncol; 2011 Feb; 18(2):358-64. PubMed ID: 21042946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
    Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
    World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology.
    Oh CA; Bae JM; Oh SJ; Choi MG; Noh JH; Sohn TS; Kim S
    J Surg Oncol; 2012 Mar; 105(4):393-9. PubMed ID: 21898416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic characteristics and outcomes of surgery of middle-third gastric cancer.
    Deng J; Liang H; Zhang R; Sun D; Pan Y; Zhang L; Hao X
    Tumour Biol; 2012 Dec; 33(6):2091-8. PubMed ID: 22869239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer.
    Fujiya K; Tokunaga M; Makuuchi R; Nishiwaki N; Omori H; Takagi W; Hirata F; Hikage M; Tanizawa Y; Bando E; Kawamura T; Terashima M
    Gastric Cancer; 2017 Mar; 20(Suppl 1):141-149. PubMed ID: 27778124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
    Li F; Zhang R; Liang H; Liu H; Quan J
    J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
    Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
    Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
    Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
    Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
    World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal of a risk score for recurrence in patients with curatively resected gastric cancer.
    Ichikura T; Fujino K; Ikawa H; Tomimatsu S; Uefuji K; Tamakuma S
    Surg Today; 1993; 23(9):759-64. PubMed ID: 8219607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of non-curative gastrectomy for incurable gastric carcinoma.
    Jeong O; Park YK; Choi WY; Ryu SY
    Ann Surg Oncol; 2014 Aug; 21(8):2587-93. PubMed ID: 24633671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative resection for advanced gastric and junctional adenocarcinoma: which patients will benefit from surgery?
    Mariette C; Bruyère E; Messager M; Pichot-Delahaye V; Paye F; Dumont F; Brachet D; Piessen G;
    Ann Surg Oncol; 2013 Apr; 20(4):1240-9. PubMed ID: 23064779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
    Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
    Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
    Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
    Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
    J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy.
    Stiekema J; Trip AK; Jansen EP; Boot H; Cats A; Ponz OB; Verheij M; van Sandick JW
    Ann Surg Oncol; 2014 Apr; 21(4):1107-14. PubMed ID: 24306660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Surveillance Interval on the Survival of Patients Who Undergo Curative Surgery for Gastric Cancer.
    Park CH; Park JC; Chung H; Shin SK; Lee SK; Cheong JH; Hyung WJ; Lee YC; Noh SH; Kim CB
    Ann Surg Oncol; 2016 Feb; 23(2):539-45. PubMed ID: 26424325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy.
    Wang SY; Yeh CN; Lee HL; Liu YY; Chao TC; Hwang TL; Jan YY; Chen MF
    Ann Surg Oncol; 2009 Oct; 16(10):2738-43. PubMed ID: 19636636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific difference in timing and pattern of initial recurrence after curative surgery for gastric cancer.
    Kim JH; Lee HH; Seo HS; Jung YJ; Park CH
    Surg Oncol; 2019 Sep; 30():81-86. PubMed ID: 31500791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.